Trends in mechanical circulatory support use and hospital mortality among patients with acute myocardial infarction and non-infarction related cardiogenic shock in the United States
- PMID: 29134345
- DOI: 10.1007/s00392-017-1182-2
Trends in mechanical circulatory support use and hospital mortality among patients with acute myocardial infarction and non-infarction related cardiogenic shock in the United States
Abstract
Background: Recent trends on outcomes in cardiogenic shock (CS) complicating acute myocardial infarction (AMI) suggest improvements in early survival. However, with the ever-changing landscape in management of CS, we sought to identify age-based trends in these outcomes and mechanical circulatory support (MCS) use among patients with both AMI and non-AMI associated shock.
Methods: We queried the 2005-2014 Nationwide Inpatient Sample databases to identify patients with a diagnosis of cardiogenic shock. Trends in the incidence of hospital-mortality, and use of MCS such as intra-aortic balloon pump (IABP), Impella/TandemHeart (IMP), and extra corporeal membrane oxygenation (ECMO) were analyzed within the overall population and among different age-categories (50 and under, 51-65, 66-80 and 81-99 years). We also made comparisons between patient groups admitted with CS complicating AMI and those with non-AMI associated CS.
Results: We studied 144,254 cases of CS, of which 55.4% cases were associated with an AMI. Between 2005 and 2014, an overall decline in IABP use (29.8-17.7%; ptrend < 0.01), and an uptrend in IMP use (0.1-2.6%; ptrend < 0.01), ECMO use (0.3-1.8%; ptrend < 0.01) and in-hospital mortality (44.1-52.5% AMI related, 49.6-53.5% non-AMI related; ptrend < 0.01) was seen. Patients aged 81-99 years had the lowest rate of MCS use (14.8%), whereas those aged 51-65 years had highest rate of MCS use (32.3%). Multivariable analysis revealed that patients aged 51-65 years (aOR 1.46, 95% CI 1.40-1.52; p<0.001), 66-80 years (aOR 2.51, 95% CI 2.39-2.63; p<0.01) and 81-99 years (aOR 5.04, 95% CI 4.78-5.32; p<0.01) had significantly higher hospital mortality compared to patients aged ≤ 50 years. Patients admitted with CS complicating AMI were older and had more comorbidities, but lower hospital mortality (45.0 vs. 48.2%; p < 0.001) when compared to non-AMI related CS. We also noted that the proportion of patients admitted with CS complicating AMI significantly decreased from 2005 to 2014 (65.3-45.6%; ptrend < 0.01) whereas those admitted without an associated AMI increased.
Conclusions: IABP use has declined whereas IMP and ECMO use has increased over time among CS admissions. Older age was associated with an incrementally higher independent risk for hospital mortality. Recent trends indicate an increase in both proportion of patients admitted with CS without associated AMI and in-hospital mortality across all CS admissions irrespective of AMI status.
Keywords: Balloon pump; Cardiogenic shock; ECMO; Impella; MCS; Mortality; Nationwide inpatient sample; Trends.
Similar articles
-
National trends, predictors of use, and in-hospital outcomes in mechanical circulatory support for cardiogenic shock.EuroIntervention. 2018 Apr 6;13(18):e2152-e2159. doi: 10.4244/EIJ-D-17-00947. EuroIntervention. 2018. PMID: 29400657
-
Hospital Variation in the Utilization of Short-Term Nondurable Mechanical Circulatory Support in Myocardial Infarction Complicated by Cardiogenic Shock.Circ Cardiovasc Interv. 2019 Jan;12(1):e007270. doi: 10.1161/CIRCINTERVENTIONS.118.007270. Circ Cardiovasc Interv. 2019. PMID: 30608880 Free PMC article.
-
US trends of in-hospital morbidity and mortality for acute myocardial infarctions complicated by cardiogenic shock.Cardiovasc Revasc Med. 2024 Jul;64:44-51. doi: 10.1016/j.carrev.2024.02.007. Epub 2024 Feb 14. Cardiovasc Revasc Med. 2024. PMID: 38378376
-
A Systematic Review and Meta-Analysis of the Efficacy and Safety of Combined Mechanical Circulatory Support in Acute Myocardial Infarction Related Cardiogenic Shock.Catheter Cardiovasc Interv. 2025 Feb;105(3):650-661. doi: 10.1002/ccd.31369. Epub 2024 Dec 24. Catheter Cardiovasc Interv. 2025. PMID: 39718168
-
Safety and utility of mechanical circulatory support in patients with acute myocardial infarction complicated by cardiogenic shock: A systematic review and meta-analysis.Cardiovasc Revasc Med. 2025 Jan;70:23-33. doi: 10.1016/j.carrev.2024.06.016. Epub 2024 Jun 21. Cardiovasc Revasc Med. 2025. PMID: 38965019
Cited by
-
Gender-based outcomes of impeller pumps percutaneous ventricular assist devices.Catheter Cardiovasc Interv. 2021 Apr 1;97(5):E627-E635. doi: 10.1002/ccd.29222. Epub 2020 Oct 15. Catheter Cardiovasc Interv. 2021. PMID: 33058477 Free PMC article.
-
Beta-Blockers as an Immunologic and Autonomic Manipulator in Critically Ill Patients: A Review of the Recent Literature.Int J Mol Sci. 2024 Jul 24;25(15):8058. doi: 10.3390/ijms25158058. Int J Mol Sci. 2024. PMID: 39125627 Free PMC article. Review.
-
Mechanical Circulatory Support Devices in Acute Myocardial Infarction-Cardiogenic Shock: Current Studies and Future Directions.J Soc Cardiovasc Angiogr Interv. 2023 Mar 27;2(2):100586. doi: 10.1016/j.jscai.2023.100586. eCollection 2023 Mar-Apr. J Soc Cardiovasc Angiogr Interv. 2023. PMID: 39129807 Free PMC article. Review.
-
An Uneven Playing Field: Demographic and Regionalized Disparities in Access to Device-Based Therapies for Cardiogenic Shock.J Soc Cardiovasc Angiogr Interv. 2023 Nov 10;3(1):101220. doi: 10.1016/j.jscai.2023.101220. eCollection 2024 Jan. J Soc Cardiovasc Angiogr Interv. 2023. PMID: 39131975 Free PMC article. No abstract available.
-
Biomarkers in cardiogenic shock: old pals, new friends.Ann Intensive Care. 2024 Oct 16;14(1):157. doi: 10.1186/s13613-024-01388-x. Ann Intensive Care. 2024. PMID: 39414666 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources